{"nct_id":"NCT05675449","title":"A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2022-12-14","start_date_type":"ACTUAL","primary_completion_date":"2026-04-22","primary_completion_date_type":"ESTIMATED","completion_date":"2028-02-29","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["PFE"]}